These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32104389)

  • 1. Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery.
    Liang W; Chan AYL; Chow MYT; Lo FFK; Qiu Y; Kwok PCL; Lam JKW
    Asian J Pharm Sci; 2018 Mar; 13(2):163-172. PubMed ID: 32104389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.
    Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
    Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
    Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.
    Chow MYT; Qiu Y; Liao Q; Kwok PCL; Chow SF; Chan HK; Lam JKW
    Int J Pharm; 2019 Dec; 572():118818. PubMed ID: 31678379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.
    Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK
    Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation.
    Chow MY; Lam JK
    Curr Pharm Des; 2015; 21(27):3854-66. PubMed ID: 26290202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.
    Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H
    J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.
    Qiu Y; Man RCH; Liao Q; Kung KLK; Chow MYT; Lam JKW
    J Control Release; 2019 Nov; 314():102-115. PubMed ID: 31629037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
    Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK
    Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of Naked Nucleic Acids under Physical Treatment and Powder Formation: Suitability for Development as Dry Powder Formulations for Inhalation.
    Okuda T; Okazaki M; Hayano A; Okamoto H
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery.
    Wang JL; Hanafy MS; Xu H; Leal J; Zhai Y; Ghosh D; Williams Iii RO; David Charles Smyth H; Cui Z
    Int J Pharm; 2021 Mar; 596():120215. PubMed ID: 33486021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.
    Ito T; Okuda T; Takayama R; Okamoto H
    J Pharm Sci; 2019 Aug; 108(8):2661-2667. PubMed ID: 30954524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
    Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.